Authors Posts by Joshua Rodriguez

Joshua Rodriguez

2784 POSTS 445 COMMENTS
Hey everyone, I'm Joshua Rodriguez. I'm the founder of CNA Finance as well as several other sites. If you'd like to connect with me, follow me on or Twitter! I'd love to see ya there. Also, if you're looking for top quality content for your blog, news outlet, or any other website for that matter, please reach out to me at Info@CNAFin.com! Legal Disclaimer - CNA Finance is NOT an investment advisor. All investment decisions should be well thought out and made with the help of a an investment advisor. For our full legal disclaimer, please scroll to the bottom right of this page.

AK Steel Holding Corporation AKS Stock News

AK Steel Holding Corporation (NYSE: AKS) is off to an incredibly strong day in the market today, and for good reason. An OSHA investigation ended just about as quickly as it started, with no problems found. Of course, this led to excitement among investors, sending the stock upward and prompting our partners at Trade Ideas to alert us to the gains. At the moment (11:55), AKS is trading at $5.90 per share after a gain of $0.34 per share (6.22%) thus far today.





AKS Investigation Closed

As mentioned above, AK Steel Holding Corporation is having a strong day in the market today after an investigation turned up no hazards. Recently, the AKS Middletown Works site was under investigation on the grounds of hazardous conditions reported. However, according to documents from the Occupational Safety and Health Administration, the investigation into the site was closed shortly after it was opened because the alleged hazardous conditions simply did not exist.




According to the allegations, “welders have no certification to weld or pressure pipes, structures, railings, etc…” The allegations also suggested that no welding logs were being kept for certification purposes. However, these allegations didn’t prove to be true. In a letter regarding the issue, Mick Paddock, Manager of Safety and Health at the West Chester Township-based company, offered the following:

In that timeframe, AK Steel has certified nearly 200 of its employees as welders…. The enclosed documents confirm that AK Steel maintains appropriate documentation of the certification of its welders, and the complaint’s vague allegation to the contrary is without merit.”

Stop wasting your time! Find winning trades in minutes with Trade Ideas!

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will continue to keep a close eye on AKS. In particular, tomorrow is likely to be a big day for the steel industry as a whole as a hearing with regard to the effect of steel imports on safety takes place, which could prove to be a massive boost for the US steel industry. We’ll continue to follow the story closely and bring the news to you as it breaks.

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required









Nokia Oyj (ADR) NOK Stock News

Nokia Oyj (ADR) (NYSE: NOK) is having an incredible start to the day in the market today, and for good reason. A long standing feud between the company and Apple (NASDAQ: AAPL) has come to an end in a very beneficial way. As can be expected, this led to excitement among investors and gains in the stock. Of course, our partners at Trade Ideas were the first to alert us to the gains. At the moment (11:33), NOK is trading at $6.58 per share after a gain of $0.36 per share or 5.88% thus far today.





NOK Settles With AAPL And Forms Collaboration Agreement

As mentioned above, Nokia is having a strong time in the market today after announcing that litigation between the company and Apple surrounding an intellectual property dispute has come to an end. The two parties have reached a settlement, and most importantly have agreed to a multi-year patent license.




According to the collaboration agreement, Apple will receive certain network infrastructure products and several services from NOK. As a result, AAPL will continue to carry NOK digital health products in the online store. Also, the two parties are in the process of exploring future collaboration opportunities surrounding digital health initiatives. Finally, both Nokia and Apple have agreed to regular summits between top executives to ensure that the relationship works effectively and to the benefit of not only both parties, but the customers of both parties. In a statement, Maria Varsellona, Chief Legal Officer at NOK had the following to offer…

This is a meaningful agreement between Nokia and Apple… It moves our relationship with Apple from being adversaries in court to business partners working for the benefit of our customers.”

Stop wasting your time! Find winning trades in minutes with Trade Ideas!

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will be keeping an incredibly close eye on both NOK and AAPL. In particular, we’re interested in following the collaboration and excited to see what the result of the collaboration becomes. Nonetheless, we’ll continue to follow the story closely and bring the news to you as it breaks!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required









Fiat Chrysler Au Rg FCAU Stock News

Fiat Chrysler Au Rg (NYSE: FCAU) was having what appeared to be a strong day in the market early on. That is, until a Department of Justice announcement came stating that they will be filing a civil suit against the company. Of course, this led to fear, causing investors to offload shares and sending the stock downward. As is normally the case, our partners at Trade Ideas were the first to alert us to the declines. At the moment (11:10), FCAU is trading at $10.56 per share after a loss of $0.20 per share (1.86%) thus far today.





FCAU Drops On DOJ Civil Suit

As mentioned above, Fiat Chrysler is off to an incredibly rough time in the market today after the United States Department of Justice made a key announcement. The announcement was that the DOJ plans to file a civil suit against FCAU as early as tomorrow.




The Department of Justice has alleged that FCAU is using what is known as a “Defeat Device” in their diesel vehicles. This device is designed to defeat the diesel emissions tests that are required by many states while not actually meeting the standards of these tests. Of course, if this goes the wrong way, it could prove to be a massive expense for Fiat Chrysler, which is why the stock is falling.

Stop wasting your time! Find winning trades in minutes with Trade Ideas!

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will be keeping a close eye on FCAU. In particular, we’re interested in following the suit that is expected to be filed against the company tomorrow and digging in to see what the suit entails. We’ll continue to follow the story closely and bring the news to you as it breaks!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required









Gevo, Inc. GEVO Stock News

Gevo, Inc. (NASDAQ: GEVO) is off to a relatively strong day in the market today, and for good reason. Arizona’s Governor has cleared the company’s renewable fuel for road use. Of course, this led to excitement among investors, sending the stock upward and prompting an alert from our partners at Trade Ideas. At the moment (10:51), GEVO is trading at $0.88 per share after a gain of $0.03 per share (3.20%) thus far today.





GEVO Gains On Arizona Road Use Clearance

As mentioned above, Gevo is having a pretty strong day in the market today after announcing that a bill that was signed by Arizona Governor Doug Ducey will allow gas stations to sell isobutanol-blended gasoline for on-road use. This means that the company’s isobutanol blend will likely soon hit gas stations in the state, offering drivers higher performance through the use of renewable fuel content.




The bill, known as Bill HB2368, allows the use of isobutanol as an axygenate in gasoline, particularly for the use of on-road vehicles in Arizona. This law will take effect in August of this year. It will add to the demand for GEVO fuels, which are already being sold in Arizona for off-road applications including boating, ATV’s, motorcycles, landscaping equipment, and more. In a statement, Dr. Patrick Gruber, CEO at GEVO, had the following to offer:

We’re excited that this bill will open up a new market for our isobutanol in Arizona. With our distribution partner Musket already serving marinas, Gevo is ready to take advantage of this new opportunity to expand isobutanol sales in the state…”

Stop wasting your time! Find winning trades in minutes with Trade Ideas!

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will be keeping a close eye on GEVO. In particular, we’re interested in following the news to see what happens to sales once isobutanol blends are able to be used in on-road applications. We’ll continue to follow the story closely and bring the news to you as it breaks!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required









0 1266
CytRx Corporation CYTR Stock News

CytRx Corporation (NASDAQ: CYTR) is having a relatively rough start to the trading session today after yesterday’s run toward the top. After a run, we tend to see cold feet among investors, who push the stock down to a more reasonable price. That seems to be what’s happening now, which caused our partners at Trade Ideas to alert us to the losses. At the moment (10:24), CYTR is trading at $0.52 per share after a loss of $0.03 per share (5.60%) thus far today. Nonetheless, it’s probably not a bad idea if you’re considering buying this dip. In fact, there are two catalysts ahead in the short term.





CYTR Catalyst #1: June 2 – 6 Data Release

The first catalyst that’s coming surrounding CytRx Corporation is the release of clinical data. The company said it will soon be offering two abstract presentations at the 2017 American Society of Clinical Oncology Annual Meeting that will be taking place between June 2nd and June 6th. Of course, this could definitely move the stock, as positive clinical data generally does.

The first bit of data to be released comes from a key Phase 3 clinical trial. During the global trial, CYTR evaluated aldoxorubicin in comparison to the investigator’s choice in patients with relapsed and refractory soft tissue sarcomas (STS).




The second bit of data that the company plans to release surrounds a Phase 1 / 2 clinical trial. During this clinical trial, the company is combining aldoxorubicin with infosfamide/mesa (I-M). The treatment is designed as a first-line and second-line treatment for STS. In a statement with regard to the CYTR data release, Daniel Levitt, M.D., Ph.D., CEO and CMO at CytRx Corporation, had the following to offer:

The data from both of these important clinical trials evaluating aldoxorubicin in sarcomas, along with our several other completed clinical and preclinical studies, will form the basis of our planned New Drug Application submission to the U.S. Food and Drug Administration, and we are pleased to share these more mature and detailed results in this peer-reviewed forum with the medical and scientific communities.”

Stop wasting your time! Find winning trades in minutes with Trade Ideas!

Catalyst 1 | Catalyst 2 | Next Page

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!
* indicates required









0 373
CytRx Corporation CYTR Stock News





CYTR Catalyst #2: July 12th Annual Meeting Of Shareholders

The second catalyst to watch out for with regard to CYTR is the coming annual meeting of shareholders. The meeting was disclosed yesterday in an SEC filing. Investors have been invited to the Hotel Bel Air in Los Angeles California to be part of the meeting. If you’d like more details on what will be discussed, click here.

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will be keeping a close eye on CYTR. In particular, we’re interested in both, the clinical data release and the result of the annual meeting, both of which could lead to incredible movement in the value of the stock. Nonetheless, we’ll continue to follow the story closely and bring the news to you as it breaks!

Stop wasting your time! Find winning trades in minutes with Trade Ideas!

Previous Page | Catalyst 1 | Catalyst 2

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required









0 179





In a statement, Ted Farnsworth, founder of Redzone had the following to offer…

Through artificial intelligence and facial recognition technology, we will seek to develop the capability to identify dangerous people entering an area and notify our users in real time… sending notifications to our users of when their safety is more likely at risk, whether at a concert, in a shopping mall, or simply walking down the street, would greatly increase the utility of RedZone Map to our users. This is a key goal in our continuing development of Redzone Map.”

Stop wasting your time! Find winning trades in minutes with Trade Ideas!

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will be keeping a close eye on HMNY and RedZone. In particular, we’re interested in seeing how the facial recognition technology is intertwined with the RedZone Map and whether or not this will lead to increased users and higher revenue. Nonetheless, we’ll continue to follow the story closely and bring the news to you as it breaks!

Previous Page | 1 | 2

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required









Helios and Matheson Analytics Inc HMNY Stock News

Helios and Matheson Analytics Inc (NASDAQ: HMNY) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company announced that it and RedZone have acquired global license rights to a key facial recognition software. Of course, this led to excitement among investors, causing gains in the stock and prompting our partners at Trade Ideas to alert us to the movement. At the moment (9:55), HMNY is trading at $4.00 per share after a gain of $1.55 per share or 63.27% thus far today.





HMNY Announces Acquisition

As mentioned above, Helios and Matheson Analytics is off to a great start in the market today after announcing that it and RedZone made a key acquisition. The two companies have acquired global license rights to IsItYou’s facial recognition technology in the field of crime and terrorism. The acquisition was acquired for integration with the RedZone Map product.

The goal of the acquisition is to integrate RedZone Map’s artificial intelligence technology and proprietary real-time crime database with the facial recognition technology. In doing so, HMNY and RedZone will allow RedZone Map users to identify people whose images they are able to capture through the smartphone’s camera. That is, if the image of the person is in the can be identified through the database within the RedZone Map.




This bodes well with RedZone’s plans on developing the ability to deliver real-time notifications of criminally active people within a given user’s area. In particular, this will be useful in large events and public spaces. However, to do so, the company will need to obtain permitted access to publicly located surveillance cameras operated by private enterprises as well as government entities.

Stop wasting your time! Find winning trades in minutes with Trade Ideas!

 1 | 2 | Next Page

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required









0 114
EnteroMedics Inc ETRM Stock News





In a statement, Dan Gladney, ETRM President, CEO and Chairman of the Board, had the following to offer…

We are excited to both incorporate BarioSurg’s Gastric Vest into our now further differentiated portfolio of medical devices for fighting obesity and related comorbidities, and to explore potential clinical opportunities to combine the Vest and vBloc Therapy®… As we move toward building a comprehensive bariatric and metabolic continuum of care platform to effectively address unmet needs within these areas, we believe that the strong foundation we’ve built at EnteroMedics will maximize the potential for a successful approval and the subsequent commercialization of this device. We look forward to sharing more details on this morning’s conference call.”

This statement was followed up by Raj Nihalani, MD, inventor of the Gastric Vest System and Founder and Former CEO at BarioSurg with the following…




EnteroMedics is a leader in minimally-invasive, sustainable weight loss treatment with vBloc Therapy. I look forward to joining the company and navigating a path toward potential FDA approval and eventual commercialization, while at the same time exploring ways in which the Vest may be able to be combined with vBloc Therapy to enhance patient outcomes.”

Stop wasting your time! Find winning trades in minutes with Trade Ideas!

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will continue to keep a close eye on ETRM. In particular, we’re interested in watching to see what Gastric Vest brings to the table as far as long run revenue. Nonetheless, we’ll continue to follow the story closely and bring the news to you as it breaks!

Previous Page | 1 | 2

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required









0 318
EnteroMedics Inc ETRM Stock News

EnteroMedics Inc (NASDAQ: ETRM) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company has announced that it has acquired BarioSurg. This led to excitement among investors, causing gains and prompting our partners at Trade Ideas to alert us to the movement. At the moment (9:24), ETRM is trading at $6.07 per share after a gain of $1.48 per share or 32.24% thus far today.





ETRM Acquires BarioSurg

As mentioned above, EnteroMedics is having a strong day in the market today after announcing that it has acquired BarioSurg, Inc. BarioSurg is the investor of Gastric Vest, an investigational, minimally-invasive, laparoscopically implanted medical device. Lining up with the ETRM vBloc, Gastric Vest is designed to help treat morbid obesity.




The Gastric Vest device is wrapped around the stomach. Once there, it emulates the effect of conventional weight loss surgery. However, the treatment doesn’t permanently change the patient’s anatomy.

Gastric Vest is also proving to be effective. In fact, in a pilot study that was conducted out of the United States, patients that were treated with Gastric Vest demonstrated a mean percent excess weight loss of 85% after 12 months. This came with an average drop in HbA1c of 2.1 points as well as an average waist circumference reduction of 38 centimeters or approximately 15 inches.

Stop wasting your time! Find winning trades in minutes with Trade Ideas!

1 | 2 | Next Page

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required









Thought Leader Discussions

Gevo, Inc. GEVO Stock News

0 5133
Gevo, Inc. (NASDAQ: GEVO) Before we get into this interview, I'd like to extend a special thanks to my friend Joey who both set up the...